Ross MaClean
General Counsel bei DrugAbuse Pharmaceutical, Inc.
Profil
Ross Maclean is Chief Executive Officer of DrugAbuse Sciences SAS.
He has been Vice President of Regulatory Affairs for DrugAbuse Pharmaceutical, Inc. since December, 2003.
Dr. Maclean received a PhD from the University of Southampton.
Aktive Positionen von Ross MaClean
| Unternehmen | Position | Beginn |
|---|---|---|
DrugAbuse Pharmaceutical, Inc.
 DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | General Counsel | - |
Ehemalige bekannte Positionen von Ross MaClean
| Unternehmen | Position | Ende |
|---|---|---|
DrugAbuse Sciences SAS
 DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | Präsident | 23.09.2008 |
Ausbildung von Ross MaClean
| The University of Southampton | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Health Technology |
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | Health Technology |
